losclouds

Enliven Therapeutics Inc.Enliven Therapeutics Inc.

Precision oncology company developing small molecule kinase inhibitor therapies targeting resistant mutations in chronic myeloid leukemia and solid tumors, with lead candidate ELVN-001 in clinical trials for treatment-resistant CML patients.

About

What Enliven Therapeutics Inc. is

Precision oncology company developing small molecule kinase inhibitor therapies targeting resistant mutations in chronic myeloid leukemia and solid tumors, with lead candidate ELVN-001 in clinical trials for treatment-resistant CML patients.

losclouds keeps public details for this profile. There are no catalog offerings to compare yet.

EnterpriseHealthcare

At a glance

Enliven Therapeutics Inc. service facts
FactValue
Official sitehttps://enliventherapeutics.com
Status coveragePublic status page
Founded2019
HeadquartersBoulder, Colorado, United States
CategoriesEnterprise, Healthcare
Loading offerings...